✦ LIBER ✦

Interim Results from Continuation-the Ongoing, Open-Label, Extension Study of Ecallantide for the Treatment of Acute Attacks of Hereditary Angioedema

✍ Scribed by MacGinnitie, A.J.; Pullman, W.E.; Horn, P.T.

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Rates of Rebound or Relapse Among Acute

✍ Li, H.H.; Bernstein, J.A.; Soteres, D.F.; Riedl, M.; Lumry, W.R.; Craig, T.J.; M 📂 Article 📅 2012 🏛 Elsevier Science 🌐 English ⚖ 37 KB

C1 Esterase Inhibitor Concentrate (C1-IN

✍ Levy, R.L.; Wasserman, R.L.; Bewtra, A.K.; Hurewitz, D.H.; Moy, J.N.; Yang, W.H. 📂 Article 📅 2009 🏛 Elsevier Science 🌐 English ⚖ 41 KB

C1 Esterase Inhibitor (C1-INH) Concentra

✍ Goodman, S.; Levy, R.; Wasserman, R.; Bewtra, A.; Hurewitz, D.; Moy, J.; Yang, W 📂 Article 📅 2010 🏛 Elsevier Science 🌐 English ⚖ 46 KB

Efficacy and safety of recombinant human

✍ D. Moldovan; A. Reshef; J. Fabiani; S. Kivity; E. Toubi; M. Shlesinger; M. Trigg 📂 Article 📅 2012 🏛 John Wiley and Sons 🌐 English ⚖ 170 KB

Subcutaneous Ecallantide for the Treatme

✍ Albert Sheffer; Patrick Horn; William Pullman 📂 Article 📅 2010 🏛 Elsevier Science 🌐 English ⚖ 44 KB

Interim results from an open-label exten

📂 Article 📅 2012 🏛 Elsevier Science 🌐 English ⚖ 47 KB